ES395533A1 - Un procedimiento para preparar composiciones farmaceuticas de liberacion prolongada a base de acido acetilsalicilico. - Google Patents

Un procedimiento para preparar composiciones farmaceuticas de liberacion prolongada a base de acido acetilsalicilico.

Info

Publication number
ES395533A1
ES395533A1 ES395533A ES395533A ES395533A1 ES 395533 A1 ES395533 A1 ES 395533A1 ES 395533 A ES395533 A ES 395533A ES 395533 A ES395533 A ES 395533A ES 395533 A1 ES395533 A1 ES 395533A1
Authority
ES
Spain
Prior art keywords
pharmaceutical compositions
sustained released
released pharmaceutical
sustained
polysiloxane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES395533A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Instituto de Angeli SpA
Original Assignee
Instituto de Angeli SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instituto de Angeli SpA filed Critical Instituto de Angeli SpA
Publication of ES395533A1 publication Critical patent/ES395533A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES395533A 1970-10-09 1971-09-29 Un procedimiento para preparar composiciones farmaceuticas de liberacion prolongada a base de acido acetilsalicilico. Expired ES395533A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4816770A GB1357737A (en) 1970-10-09 1970-10-09 Sustained release pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ES395533A1 true ES395533A1 (es) 1974-10-16

Family

ID=10447626

Family Applications (1)

Application Number Title Priority Date Filing Date
ES395533A Expired ES395533A1 (es) 1970-10-09 1971-09-29 Un procedimiento para preparar composiciones farmaceuticas de liberacion prolongada a base de acido acetilsalicilico.

Country Status (8)

Country Link
US (1) US3853988A (OSRAM)
CA (1) CA974883A (OSRAM)
DE (1) DE2149699A1 (OSRAM)
DK (1) DK129434B (OSRAM)
ES (1) ES395533A1 (OSRAM)
FR (1) FR2110314B1 (OSRAM)
GB (1) GB1357737A (OSRAM)
SE (1) SE382560B (OSRAM)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51123814A (en) * 1975-04-22 1976-10-28 Shin Etsu Chem Co Ltd A process for preparing gradually releasable solid medicines
US4167558A (en) 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
DE2902414A1 (de) * 1979-01-23 1980-08-07 Hoechst Ag Depotkoerper auf basis silicon- kautschuk sowie verfahren zu seiner herstellung
FR2514261B1 (fr) * 1981-10-08 1986-08-22 Aec Chim Organ Biolog Nouvelle composition pour l'enrobage des aliments et des medicaments et granules ainsi enrobes
DE3508097A1 (de) * 1984-07-21 1986-02-06 Hoechst Ag, 6230 Frankfurt Kombinationspraeparat aus xanthinderivaten und o-acetylsalicylsaeure bzw. deren pharmakologisch vertraeglichen salzen und dessen verwendung
FR2653338B1 (fr) * 1989-10-23 1994-06-10 Dow Corning Sa Formulation pour des pansements a liberation prolongee de medicament et son utilisation.
DE4409357C2 (de) * 1994-03-18 1996-10-17 Upmeyer Hans Juergen Verwendung von Dimeticon zur Eradikation von Heliobacter pylori
CZ300696A3 (en) * 1994-03-18 1997-09-17 Alfred Schmidt USE OF DEMETICON FOR PREPARING A PHARMACEUTICAL COMPOSITION FOR LOCAL AND ANTIBACTERIAL THERAPY AND/OR PREVENTION AND THERAPY OF SYNDROMES AND INFECTIOUS DISEASES CONNECTED WITH HELIOBACTER PYLORI (Hp)
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
WO1997002019A1 (en) * 1995-06-30 1997-01-23 Baylor University Polyester/carboxylic acid composite materials
US20110039807A1 (en) * 2009-08-13 2011-02-17 Kim Hyoung-Chun Anti-parkinsonian compound acetylsalicylic acid maltol ester
WO2014014753A1 (en) * 2012-07-17 2014-01-23 Dow Global Technologies Llc Composition comprising an organic liquid diluent and a cellulose ether of very low viscosity

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2805977A (en) * 1955-01-04 1957-09-10 Smith Kline French Lab Sustained release pharmaceutical preparation
GB971486A (en) * 1960-04-01 1964-09-30 Rech S Pharma Et Scient Therapeutic compositions comprising aspirin and polysiloxanes
US3133863A (en) * 1961-03-10 1964-05-19 Strong Cobb Arner Inc Sustained release therapeutic tablet compositions comprising organic solvent-gelled gums
AU407324B2 (en) * 1962-05-01 1970-10-28 Smith, Kline & French Laboratories Powdered silicone products and processes
US3501571A (en) * 1965-12-06 1970-03-17 Smithkline Corp Novel silicone compositions and method of preparing same
US3518344A (en) * 1967-10-02 1970-06-30 Miles Lab Tableting lubricant

Also Published As

Publication number Publication date
US3853988A (en) 1974-12-10
FR2110314A1 (OSRAM) 1972-06-02
DE2149699A1 (de) 1972-04-13
FR2110314B1 (OSRAM) 1975-06-06
GB1357737A (en) 1974-06-26
CA974883A (en) 1975-09-23
DK129434B (da) 1974-10-14
SE382560B (sv) 1976-02-09
DK129434C (OSRAM) 1975-03-10

Similar Documents

Publication Publication Date Title
ES403435A1 (es) Metodo para la preparacion de una composicion farmaceutica de liberacion lenta.
CA936472A (en) Formulation for sustained release of a biological agent
IL43839A0 (en) Compositions for sustained release of a medicament
ES395533A1 (es) Un procedimiento para preparar composiciones farmaceuticas de liberacion prolongada a base de acido acetilsalicilico.
AU458705B2 (en) Improvements in or relating to pharmaceutical compositions
ES370058A1 (es) Procedimiento para la preparacion de composiciones farma- ceuticas efervescentes.
AU8251275A (en) Pharmaceutical compositions comprising 6,8-diethyl-5-hydroxy-4-oxo-4h-1-benzopyran-2-carboxylic acid, and their uses
IL40685A0 (en) Pharmaceutical compositions for the dissolution of renal calculi and their preparation
IL37013A (en) Basically substituted alkylidene-aminooxyalkyl-carboxylic acid esters,their preparation and pharmaceutical compositions containing them
PH12292A (en) 7b-(d-5-amino-5-carboxyvaleramido)-7-methoxy-3-cephem 4-carboxylic acids and pharmacologically acceptable salts thereof and pharmaceutical compositions containing same
AU2441971A (en) Firefighting and compositions for use therein
IL36289A (en) Highly stable anaerobic compositions comprising acrylate ester monomer
GB1126153A (en) Novel polygalacturonic acid derivative
BE764768A (fr) Compositions pharmaceutiques
CA958643A (en) Pharmaceutical compositions containing cyclobenzaprine
IL37139A0 (en) Triakoxybenzoyl aminoalkanoic acid derivatives and pharmaceutical compositions containing them
ZA714785B (en) A pharmaceutical composition containing a pharmaceutically active compound
CA981583A (en) Pharmaceutical compositions containing dantrolene sodium
CA991653A (en) Sulphonic acid esters, their preparation, and their medicinal use
GB1287433A (en) Pharmaceutical compositions
CA843403A (en) Sustained release medicinal tablets
IL37623A0 (en) Theophylline isobutyrate salts,their preparation and pharmaceutical compositions containing them
AU456249B2 (en) Pharmaceutical compositions containing 4 hydroxynicotinic acid
IL37919A (en) Esters of 1,3-aminoalcohols and their salts,their preparation and pharmaceutical compositions containing them
IL30297A0 (en) Bis-(p-chlorophenoxy)-acetic acid alkyl esters,their preparation and pharmaceutical compositions containing them